Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. (2018)

First Author: Newsome PN
Attributed to:  MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(17)30326-6

PubMed Identifier: 29127060

Publication URI: http://europepmc.org/abstract/MED/29127060

Type: Journal Article/Review

Volume: 3

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 1